Eledon Pharmaceuticals, Inc.
ELDN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$17 | -$11 | -$6 | -$45 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2 | $3 | $3 | $7 |
| Change in WC | $3 | $3 | -$2 | -$2 |
| Other Non-Cash | -$2 | -$13 | -$11 | $20 |
| Operating Cash Flow | -$14 | -$18 | -$16 | -$19 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$33 | -$27 | -$32 | -$73 |
| Inv. Sales/Matur. | $45 | $42 | $36 | $25 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $12 | $15 | $4 | -$47 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | -$0 | $0 | $0 | $80 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $0 | $0 | $0 | $80 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$2 | -$3 | -$12 | $14 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $6 | $8 | $21 | $7 |
| End Cash | $4 | $6 | $8 | $21 |
| Free Cash Flow | -$14 | -$18 | -$16 | -$19 |